Santaris Adds miR-33 to Its Pipeline Via Mass General Licensing Deal
March 03, 2011
Santaris Adds miR-33 to Its Pipeline Via Mass General Licensing Deal
The microRNA has been shown to suppress a protein important for the generation of high-density lipoprotein and for the removal of of cholesterol from peripheral tissues, according to the company.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.